Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Researchers found a way to make rat hair follicle cells start turning into motor neuron-like cells, but couldn't fully turn them into working motor neurons.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Alopecia areata treatment varies, with no optimal method established yet.

The document provides ways to tell alopecia areata from other similar hair loss conditions, using visual checks and specific tests.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

PRP is an effective and safe treatment for alopecia areata.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

Fzd2 is important for skin and hair development through various signaling ways.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Finasteride may cause kidney damage.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.